Specific IgE antibodies in patients with isocyanate asthma.
D000906:Antibodies / Q000276:immunology*; D001249:Asthma / Q000139:chemically induced / Q000276:immunology*; D001559:Benzhydryl Compounds / Q000009:adverse effects; D003485:Cyanates / Q000009:adverse effects*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D017953:Isocyanates; D014051:Toluene 2,4-Diisocyanate / Q000009:adverse effects
D000906:Antibodies; D001559:Benzhydryl Compounds; D003485:Cyanates; D017953:Isocyanates; C015262:1,6-hexamethylene diisocyanate; D014051:Toluene 2,4-Diisocyanate; D007073:Immunoglobulin E; C005969:4,4'-diphenylmethane diisocyanate